Reply: Relevance of Indications for CABG in Evaluating the Effect of Dual Antiplatelet Therapy.


The secondary analysis of the FREEDOM (Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease) study data (1) leaves unanswered the question of whether patients with acute coronary syndromes (ACS) undergoing coronary artery bypass grafting [CABG] derive benefit from dual antiplatelet therapy (DAPT… (More)
DOI: 10.1016/j.jacc.2017.04.063